Julia Boshuizen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Venues

Nature communications

Nature medicine

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

Netherlands Cancer Institute

Erasmus University Rotterdam (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Netherlands Cancer Institute Jul 21 2015 - Mar 31 2020

Netherlands

PhD student :: Molecular Oncology and Immunology

Education History

Erasmus University Rotterdam Sep 01 2013 - Jul 01 2015

Netherlands

MSC

Publications

Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T Frederick, Juliana C N Kenski, Mara Parren, Marieke Brüggemann, Max F Madu, Elisa A Rozeman, Ji-Ying Song, Hugo Mark Horlings, Christian U Blank, Alexander C J van Akkooi, Keith T Flaherty, Genevieve Marie Boland, Daniel S Peeper
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nature communications 14 (1) (2023)
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T Frederick, Juliana C N Kenski, Mara Parren, Marieke Brüggemann, Max F Madu, Elisa A Rozeman, Ji-Ying Song, Hugo Mark Horlings, Christian U Blank, Alexander C J van Akkooi, Keith T Flaherty, Genevieve Marie Boland, Daniel S Peeper
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nature communications 14 (1) (2023)
Julia Boshuizen, Nora Pencheva, Oscar Krijgsman, Daniela D'Empaire Altimari, Patricia Garrido Castro, Beaunelle de Bruijn, Maarten A Ligtenberg, Elke Gresnigt-Van den Heuvel, David W Vredevoogd, Ji-Ying Song, Nils Visser, Georgi Apriamashvili, Maarten L Janmaat, Theo S Plantinga, Patrick Franken, Mischa Houtkamp, Andreas Lingnau, Maria Jure-Kunkel, Daniel S Peeper
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade. Cancer research 81 (7) (2021)
Oscar Krijgsman, Kristel Kemper, Julia Boshuizen, David W Vredevoogd, Elisa A Rozeman, Sofia Ibanez Molero, Beaunelle de Bruijn, Paulien Cornelissen-Steijger, Aida Shahrabi, Martin Del Castillo Velasco-Herrera, Ji-Ying Song, Maarten A Ligtenberg, Roelof J C Kluin, Thomas Kuilman, Petra Ross-MacDonald, John B A G Haanen, David J Adams, Christian U Blank, Daniel S Peeper
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T Frederick, Juliana C N Kenski, Mara Parren, Marieke Brüggemann, Max F Madu, Elisa A Rozeman, Ji-Ying Song, Hugo Mark Horlings, Christian U Blank, Alexander C J van Akkooi, Keith T Flaherty, Genevieve Marie Boland, Daniel S Peeper
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nature communications 11 (1) (2020)
Julia Boshuizen, Louise A Koopman, Oscar Krijgsman, Aida Shahrabi, Elke Gresnigt- van den Heuvel, Maarten A Ligtenberg, David W Vredevoogd, Kristel Kemper, Thomas Kuilman, Ji-Ying Song, Nora Pencheva, Jens Thing Mortensen, Marnix Geukes Foppen, Elisa A Rozeman, Christian U Blank, Maarten L Janmaat, David Satijn, Esther C W Breij, Daniel S Peeper, Paul W H I Parren
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors. Nature medicine 24 (2) (2018)

Julia Boshuizen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Julia Boshuizen